Skip to Content

Avanafil Pregnancy and Breastfeeding Warnings

Avanafil is also known as: Stendra

Medically reviewed on Nov 6, 2017

Avanafil Pregnancy Warnings

Animal studies have failed to reveal evidence of teratogenicity, embryotoxicity or fetotoxicity. There are no adequate and well controlled studies in pregnant women.

Not indicated for use in females.

US FDA pregnancy category: C

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Avanafil Breastfeeding Warnings

No Literature
Not indicated for use in females

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

See references

References for pregnancy information

  1. "Product Information. Stendra (avanafil)." Vivus Inc, Mountain View, CA.
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

References for breastfeeding information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. "Product Information. Stendra (avanafil)." Vivus Inc, Mountain View, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide